Walking With FES or AFO in People With MS With Foot Drop
A Pilot Study to Assess the Effects of Using FES or AFO as an Assistive Mobility for Period of 12 Weeks for People With Multiple Sclerosis With Foot Drop
Sponsor: Multiple Sclerosis Society UK
Listed as NCT01977287, this observational or N/A phase trial focuses on Foot Drop and Multiple Sclerosis and remains completed. Sponsored by Multiple Sclerosis Society UK, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Multiple Sclerosis Society UK
- NHS Lothian
- Queen Margaret University
For direct contact, visit the study record on ClinicalTrials.gov .